EMEA-002184-PIP01-17-M01
Key facts
| Active substance |
Solriamfetol
|
| Therapeutic area |
Neurology
|
| Decision number |
P/0394/2021
|
| PIP number |
EMEA-002184-PIP01-17-M01
|
| Pharmaceutical form(s) |
Tablet
|
| Condition(s) / indication(s) |
|
| Route(s) of administration |
Oral use
|
| Contact for public enquiries |
Jazz Pharmaceuticals Ireland Limited
E-mail: medinfo-int@jazzpharma.com |
| Decision type |
PM: decision on the application for modification of an agreed PIP
|